Edgewise Therapeutics (EWTX) executive Donovan sold 2,862 shares for $38.3K at $13.39

Insider transactions reported

Joanne M. Donovan (Cmo at Edgewise Therapeutics Inc., EWTX) reported that they sold 2,862 shares for $38.3K at $13.39, and acquired 5,781 shares on Aug 12, 2025. After these transactions the filing shows 25,361 shares held directly.

Reporting person

Donovan Joanne M.

Role

CMO

Options and other derivatives

Holdings before and after

• Common Stock: 22,442 to 25,361 direct
• Restricted Stock Units: 23,125 to 28,125 direct
• Stock Option (Right to Buy): 0 to 168,750 direct

Footnotes from the filing

1. 1. Includes 854 shares purchased on May 15, 2025 pursuant to the Edgewise Therapeutics, Inc. 2021 Employee Stock Purchase Plan.
2. 2. Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs). This sale satisfies the minimum statutory tax withholding obligations to be funded by a sell-to-cover transaction and does not represent a discretionary sale by the Reporting Person
3. 3. The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $13.36 to $13.49, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
4. 4. Restricted Stock Units ( RSUs ) granted to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in four equal annual installments beginning on August 12, 2025.
5. 6. 1/48th of the shares subject to the option vest each month beginning on September 12, 2025, subject to the Reporting Person continuing as a service provider through each vest date.

Transaction codes in this filing

Open-market sale:

Code S marks a sale in the open market or a private deal. The insider received cash for these securities.

Exercise or conversion of a derivative:

Code M marks the exercise or conversion of an option or other derivative under an exempt plan.

FAQ